Article Text

PDF
Use of prostaglandins in duct-dependent congenital heart conditions
  1. Yogen Singh1,
  2. Paraskevi Mikrou2
  1. 1Department of Neonatology and Paediatric Cardiology, Cambridge University Hospitals NHS Foundation Trust and University of Cambridge, Cambridge, UK
  2. 2Health Education England (West Midlands), Birmingham, UK
  1. Correspondence to Dr Yogen Singh, Department of Neonatology and Paediatric Cardiology, University of Cambridge, Box 402, NICU, Addenbrooke’s Hospital, Biomedical Campus, Cambridge CB20QQ, UK; Yogen.Singh{at}nhs.net

Abstract

Congenital heart disease (CHD) remains a leading cause of infant mortality, which is even higher in infants with undiagnosed duct-dependent CHDs. Up to 39%–50% of infants with critical CHD are being discharged undiagnosed from the hospital. Infants with duct-dependent critical CHD remain well during the fetal period and may deteriorate when the ductus arteriosus (commonly called ‘duct’) closes after birth. It is critical to open or maintain ductus arteriosus patent in infants with duct-dependent CHDs. Prostaglandin E1 (alprostadil marketed as ‘Prostin VR ’) and prostaglandin E2 (dinoprostone) are used to maintain a patent ductus arteriosus and the dose of medication depends on the clinical presentation. Delay in starting prostaglandin infusion can have deleterious effects on infants and can even lead to death. These infants often present as an emergency, and professionals caring for these infants need to have a good understanding of these conditions and medications used for ductal patency.

  • ductus arteriosus
  • duct dependent
  • congenital heart defects
  • prostaglandin
  • dinoprostone/alprostadil

Statistics from Altmetric.com

Footnotes

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.